Skip to main content

Carrie Jones, Ph.D.

Associate Professor of Pharmacology

Teaches NSC 3245 Drug Discovery for Neuropsychiatric Disorders

Carrie Jones received her B.S. in Biology from Indiana University and further completed her Ph.D. from the Indiana University School of Medicine. While obtaining her Ph.D., she began her work in the Neuroscience division of pharmacology at Lily Research Laboratories, starting in 2001 on her first Postdoctoral Research Fellowship there. In 2005, Dr. Jones embarked on further postdoctoral studies within Vanderbilt University’s Department of Pharmacology.

Dr. Jones joined the Vanderbilt Center for Neuroscience Drug Discovery in 2005, and now serves as the Director of Behavioral Pharmacology and is an Assistant Professor of Pharmacology. Her In Vivo Pharmacology team is dedicated to utilizing translational approaches, including assessment of changes in behavior, neurochemistry and imaging endpoints such as PET and functional MRI, to explore the underlying mechanisms of novel ligands targeting different G protein-coupled receptors (GPCR) and transporters within the CNS and the implications of these effects on different disease states, most notably schizophrenia.